Here are 4 forces that drove a tough week for stocks

1 day ago

CDC says massive cyclospora outbreak is now in nine states

2 days ago

Cyclospora outbreak tests RFK Jr.'s promise to overhaul food system

2 days ago

Eli Lilly says it will file for approval of next-generation obesity drug in 2027

3 days ago

Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says

3 days ago

What Trump's generic drug tariffs could mean for patients, drugmakers and prices

4 days ago

RFK Jr. says cyclospora outbreak is 'under control'

5 days ago

Cardinal Health's latest deals won't move the needle overnight. They still matter.

5 days ago

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

5 days ago

The FDA made a reversal on cyclosporiasis, but it still thinks iceberg lettuce is to blame

5 days ago

What to know about testosterone replacement as U.S. military plans to test troops

6 days ago

Market case for psychedelic drugs to treat mental health gets a big buy signal

6 days ago

Fat cat? Weight-loss drugs may be coming for your overweight pet

9 days ago

Trump rips Canada for wildfire smoke, threatens to raise tariffs

9 days ago

Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants

9 days ago

World's largest olive oil company says market has 'definitively' entered new phase

10 days ago

Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape

10 days ago

3 of our stocks rode the AI rally, while 3 others fell out of favor since last month

10 days ago

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion

10 days ago

UnitedHealth beats quarterly estimates, hikes profit outlook

11 days ago

J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

11 days ago

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

12 days ago

A tiny GLP-1 implant is the latest bet to help patients maintain weight loss

12 days ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?

15 days ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer

16 days ago

AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse

17 days ago

Employers aren't expanding coverage of GLP-1 obesity drugs, survey says

18 days ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

20 days ago

Ebola outbreak harder to contain after USAID, Western aid cuts, experts say

20 days ago

Jim Cramer says this former Covid market darling is finally investable again

25 days ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

25 days ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

26 days ago